News
Glycolipids with TLR4 agonistic properties can serve either as therapeutic agents or as vaccine adjuvants by stimulating the development of proinflammatory responses. Translating them to the clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results